FDAnews
www.fdanews.com/articles/85406-guidant-announces-enrollment-of-first-patient-in-landmark-carotid-artery-stenting-study

GUIDANT ANNOUNCES ENROLLMENT OF FIRST PATIENT IN LANDMARK CAROTID ARTERY STENTING STUDY

March 20, 2006

Guidant Corporation today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in high surgical risk patients, called CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). WebWire (http://webwire.com/ViewPressRel.asp?SESSIONID=&aId=11244)